Skip to main content
. 2022 Mar 30;13:822004. doi: 10.3389/fimmu.2022.822004

Table 7.

Top 5 citing References in cluster #15 of the overlay analysis of co-cited references and keywords.

Coverage Reference Citations Author Year Type Journal IF JCR
4 B7-H3-targeted CAR-T cells exhibit potent antitumor effects on hematologic and solid tumors 18 Zhang Zongliang 2020 Article Molecular Therapy: Oncolytics 7.200 Q4
4 Targeting B7-H3 immune checkpoint with chimeric antigen receptor-engineered natural killer cells exhibits potent cytotoxicity against non-small cell lung cancer 10 Yang Shuo 2020 Article Frontiers in Pharmacology 5.810 Q1
4 Route of 41BB/41BBL costimulation determines effector function of B7-H3-CAR.CD28z T cells 8 Nguyen Phuong 2020 Article Molecular Therapy: Oncolytics 7.200 Q4
4 MEK inhibitor augments antitumor activity of B7-H3-redirected bispecific antibody 5 Li Hongjian 2020 Article Frontiers in Oncology 6.244 Q2
4 Chimeric antigen receptor T-cell therapy in glioblastoma: current and future 3 Li Long 2020 Review Frontiers in Immunology 7.561 Q2

IF, impact factors; JCR, journal citation reports.